Tanox
Executive Summary
Signs $13 mil. deal with Takara Shuzo for the development of a treatment for IgA nephropathy using Tanox' migis technology, Houston-based Tanox announces Nov. 14. Takara Shuzo, a Japanese brewery with a biotech division specializing in diagnostics and reagents, will pay Tanox an initial license fee, fund R&D, and make milestone payments over four-and- a-half years to equal the $13 mil., more than twice the $6 mil. in cash Tanox now has on hand